• Darifenacin Prolonged Release Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.

    Active IngredientStrengthPrimary Clinical Function
    Darifenacin Hydrobromide USP/Ph.Eur.
    (Equivalent to Darifenacin base)
    7.5 mg (PR)The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects.
    Darifenacin Hydrobromide USP/Ph.Eur.15 mg (PR)The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose.
    ExcipientsHypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric FilmHydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).

  • Memantine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips, frequently customized into 4-week Titration Starter Packs.

    Active IngredientStrengthPrimary Clinical Function
    Memantine (as Hydrochloride) USP/Ph.Eur.5 mgInitiation / Titration Standard: Base therapeutic unit utilized exclusively for the mandatory 4-week step-up protocol to build patient tolerance and prevent severe CNS adverse effects.
    Memantine (as Hydrochloride) USP/Ph.Eur.10 mgGlobal Neurology Standard: High-efficacy adult maintenance dose, typically taken twice daily, for the sustained neuroprotection of the degenerating brain.
    ExcipientsMicrocrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry FilmDiluent / Binder / Superdisintegrant / Slipper-Coating (Engineered specifically with a heavy, smooth film-coat to ensure immediate gastric transit and absolute ease of swallowing for elderly patients suffering from severe dysphagia)

    *Pack Sizes: 10×10 Blisters, Bottles of 60, or Customized 28-Day Titration Starter Kits (Optimized specifically for strict chronic geriatric dispensing regimens).

  • Mirabegron Extended-Release Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.

    Active IngredientStrengthPrimary Clinical Function
    Mirabegron Ph.Eur./USP25 mg (ER)Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment.
    Mirabegron Ph.Eur./USP50 mg (ER)Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity.
    ExcipientsPolyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry FilmSwellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).